Triiodoisophthalamide X-ray contrast agent

Details Triiodoisophthalamide X-ray contrast agent Triiodoisophthalamide X-ray contrast agent

1982-01-11

1983-08-02

Helfin, Bernard

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Molecular bilayer structure

564156, A61K 4904, C07C10324

Patent

active

043965989

ABSTRACT:
Novel X-ray contrast agents, i.e., N,N'-bis(2,3-dihydroxypropyl)-5-N-(2-hydroxyethyl)glycolamido-2,4,6-triiod oisophthalamide.

REFERENCES:
patent: 4001323 (1977-01-01), Felder et al.
patent: 4021481 (1977-05-01), Almen et al.
patent: 4250113 (1981-02-01), Nordal et al.
patent: 4278654 (1981-07-01), Rakli et al.

Affiliated with

Also associated with

Rating

Triiodoisophthalamide X-ray contrast agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triiodoisophthalamide X-ray contrast agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triiodoisophthalamide X-ray contrast agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-483685